ArticleJournal of chemical information and modeling2026
Probing the Structural Dynamics of the Unbound MAX Protein: Insights from Well-Tempered Metadynamics.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Whole-Genome Sequencing of Multidrug-ResistantInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of most relevant challenges in tumorigenesis is the association of MYC and MAX proteins, whose related cancers remain undrugged. In particular, the disordered regions shown by those oncogenes make their structural characterization and the development of new drugs a truly hard task. To address these challenges, we employed the enhanced-sampling well-tempered metadynamics method to systematically explore the conformational space of the unbound MAX protein. Our results revealed, for the first time, a well-defined and thermodynamically favorable conformation of monomeric MAX. This is a remarkable finding, as it demonstrates that regions of MAX previously considered persistently disordered are capable of adopting stable, folded structures under specific conditions. Moreover, our findings also suggest that the metastable structural motifs observed in this work may harbor druggable sites, particularly relevant for strategies aiming to target MAX directly or to disrupt its interaction with MYC, thereby modulating oncogenic signaling pathways. The present study establishes a new structural framework for understanding the dynamics of MAX and provides a foundation for future structure-based drug design targeting the MYC/MAX axis. Finally, our work offers a strategic blueprint for investigating similarly challenging drug targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.